Gut & MicrobiomeResearch PaperPaywall

Sea cucumber hydrolysate protects aging mice's memory, muscle and gut microbiome

In a D-galactose mouse aging model, an enzymatic sea cucumber hydrolysate improved memory, muscle, antioxidant enzymes and gut bacteria. Human data are lacking.

Saturday, November 21, 2026 0 views
Published in Food Res Int
dried sea cucumbers and a bowl of pale hydrolysate powder on a wooden table beside a lab mouse cage

Summary

Sea cucumber is a traditional food credited with anti-aging effects. Researchers compared four products made from Stichopus japonicus (freeze-dried powder, enzymatic hydrolysate powder, purified polysaccharides and purified peptides) in mice made to age prematurely with D-galactose injections. The enzymatic hydrolysate powder (SCEP) gave the best overall pattern. Treated mice showed less memory impairment and less muscle loss, higher antioxidant enzyme activity, lower markers of inflammation, and calmer immune cells in the hippocampus, a memory region of the brain. Their gut bacteria shifted toward groups linked with gut health, and short-chain fatty acids were restored. This is a mouse study in a chemically induced aging model, which mimics some aging features but not natural aging. Lifespan was not reported, and nothing has been tested in people yet. It is a mechanism worth watching, not a basis for dosing advice.

Detailed Summary

Why this matters: Oxidative stress, chronic low-grade inflammation, gut dysbiosis, muscle loss and cognitive decline are interlinked features of aging. Food-derived products that touch several of these at once are attractive, but most evidence is preclinical. Sea cucumber is a long-used food in East Asia, and enzymatic hydrolysis breaks its proteins into smaller fragments that may be more bioactive.

What was studied: Researchers tested four Stichopus japonicus products in mice given D-galactose to induce an aging-like state: freeze-dried powder (SCDP), enzymatic hydrolysate powder (SCEP), purified polysaccharides (SCSP) and purified peptides (SCP). Each was given at a matrix-relevant dose. The abstract does not give group sizes, duration or exact doses.

Key results: SCEP showed the most favorable overall pattern. Function: it reduced memory impairment and age-related muscle loss. Mechanism: versus the D-galactose group, it raised catalase by 31.34% in liver and 39.81% in serum, glutathione peroxidase by 138.09% and 41.43%, and superoxide dismutase by 32.67% and 17.48%. It lowered malondialdehyde, serum TNF-alpha by 22.20% and IL-1beta by 18.98%. In the hippocampus it suppressed GFAP and Iba-1, indicating less astrocyte and microglia activation. Gut microbiome: Dubosiella rose 94.8%, Lachnospiraceae NK4A136 group 166.5%, and Mammaliicoccus fell 60.0%, with restored short-chain fatty acids and improved metabolic profiles. Lifespan was not reported.

Implications: The data suggest a hydrolyzed sea cucumber product may act on antioxidant, inflammatory and gut-microbial pathways together, and that hydrolysis may matter. Whether the microbiome shift drives the benefits is not shown; these are parallel changes.

Caveats: This is a mouse model of induced aging, not natural aging, based only on the abstract. No human data exist, and the comparison versus the other three products is only described as an overall pattern.

Key Findings

  • In D-galactose aging mice, the enzymatic hydrolysate (SCEP) outperformed freeze-dried powder, polysaccharides and peptides on overall anti-aging response.
  • Function: SCEP alleviated memory impairment and age-related muscle loss in the mouse model.
  • Mechanism: SCEP raised liver GSH-Px 138.09% and lowered serum TNF-alpha 22.20% and IL-1beta 18.98% versus D-galactose alone.
  • SCEP reduced hippocampal GFAP and Iba-1, indicating less astrocyte and microglia activation.
  • Microbiome: Dubosiella and Lachnospiraceae NK4A136 rose, Mammaliicoccus fell, with restored short-chain fatty acids; lifespan not reported.

Methodology

Preclinical study in a D-galactose-induced aging mouse model comparing four Stichopus japonicus products at matrix-relevant doses against a D-galactose control. Endpoints included behavior (memory), muscle, oxidative and inflammatory markers, hippocampal histology/expression, gut microbiota and short-chain fatty acids. Sample size, duration and doses were not given in the abstract.

Study Limitations

This summary is based on the abstract only, so design details, statistics and dosing were unavailable. D-galactose-induced aging is an accelerated model that does not fully reflect natural aging, mice are not humans, and lifespan and causality between microbiome changes and benefits were not shown.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: